Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06971640 · ClinicalTrials.gov registry record

Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition

A clinical trial of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, sponsored by Duke University.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT06971640 is a study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity that is actively recruiting participants, run by Duke University. The registered enrollment target is 250 participants, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06971640, a study of ADHD and ADHD - Attention Deficit Disorder With Hyperactivity, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The investigator for this study is Dr. Jessica Lunsford-Avery from the Department of Psychiatry.

Study Locations (1)

North Carolina

  • Duke University Medical Center - Durham

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2025-05-28
Est. Completion 2029-11

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT06971640

The ClinicalTrials.gov registry entry for NCT06971640 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 187-participant average among 75 other ADHD trials with a reported enrollment target (34% higher). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with ADHD appearing as the primary indexed condition, and to 0 interventions.

NCT06971640 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT06971640 about?

NCT06971640 is a clinical study titled "Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition". The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The ...

What is the current status of trial NCT06971640?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2025-05-28. Estimated completion is 2029-11.

What conditions does trial NCT06971640 study?

This clinical trial studies the following conditions: ADHD, ADHD - Attention Deficit Disorder With Hyperactivity.

Who is sponsoring clinical trial NCT06971640?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06971640 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for ADHD

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.